Award
Delivery Order #SPE2D226F1385
Delivery Order for Haloperidol Injection under Pharmaceutical IDV
Buyer
Defense Logistics Agency
Award Amount
$80.18
Ceiling
$80.18
Awarded
February 26, 2026
Period of Performance
Feb 26, 2026 – Feb 26, 2026
Identifier
SPE2D226F1385
NAICS
325411
This award is a delivery order contract issued to DMS Pharmaceutical Group Inc., a prominent pharmaceutical manufacturer and distributor known for supplying essential medications to government agencies. The contract specifically pertains to the procurement of Haloperidol Injection, a critical pharmaceutical product. This delivery order is part of a broader indefinite delivery vehicle (IDV) contract previously awarded to DMS Pharmaceutical Group, which ensures a steady and reliable supply of a wide range of drug products crucial for government health services. The contract holds significant importance by supporting public healthcare systems in maintaining timely access to vital medications. The scope of this delivery order covers the provision of Haloperidol Injection, scheduled for fulfillment on a specified short-term timeline. This contract was awarded under an existing IDV agreement, which was competitively bid to promote sustained and efficient pharmaceutical supply. While detailed subcontractor information is not available for this delivery order, the overarching IDV contract exemplifies a substantial multi-year commitment to enhancing government healthcare capabilities.
Description
8511947817!HALOPERIDOL INJECTI